| scholarly article | Q13442814 |
| P50 | author | Peter D. Mace | Q42423701 |
| P2093 | author name string | John C Reed | |
| Kate Welsh | |||
| Hongbin Yuan | |||
| Stefan J Riedl | |||
| Ying Su | |||
| Kristiina Vuori | |||
| Nicholas D P Cosford | |||
| Peter Teriete | |||
| Robert J Ardecky | |||
| Darren Finlay | |||
| Marcos González-López | |||
| Santhi Reddy Ganji | |||
| P2860 | cites work | Structural basis of caspase-7 inhibition by XIAP | Q24290942 |
| Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain | Q24290943 | ||
| Structural basis for the inhibition of caspase-3 by XIAP | Q24290945 | ||
| PHENIX: a comprehensive Python-based system for macromolecular structure solution | Q24654617 | ||
| Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain | Q27629143 | ||
| Structural basis of IAP recognition by Smac/DIABLO | Q27629148 | ||
| A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis | Q28204205 | ||
| IAP family proteins--suppressors of apoptosis | Q28297514 | ||
| Structural Basis of Caspase Inhibition by XIAP | Q29011600 | ||
| Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity | Q31038912 | ||
| Apoptosis in cancer | Q33846227 | ||
| Targeting XIAP for the treatment of malignancy | Q33991803 | ||
| Cyclopeptide Smac mimetics as antagonists of IAP proteins | Q34382271 | ||
| Human caspases: activation, specificity, and regulation | Q34608215 | ||
| Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity. | Q35024837 | ||
| Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology | Q35874476 | ||
| The apoptosome: signalling platform of cell death | Q36766418 | ||
| Neuronal apoptosis in neurodegeneration | Q36850374 | ||
| X-linked inhibitor of apoptosis protein as a therapeutic target | Q37008849 | ||
| Design of small-molecule peptidic and nonpeptidic Smac mimetics | Q37176751 | ||
| IAP-targeted therapies for cancer | Q37302745 | ||
| IAP antagonists: promising candidates for cancer therapy | Q37680131 | ||
| Small-molecule pan-IAP antagonists: a patent review | Q37680967 | ||
| Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer | Q40524353 | ||
| Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. | Q45027288 | ||
| Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics. | Q53873372 | ||
| Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain | Q83459597 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein design | Q410814 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 4332-4336 | |
| P577 | publication date | 2011-05-24 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP | |
| P478 | volume | 21 |
| Q54268307 | A critical role for cellular inhibitor of protein 2 (cIAP2) in colitis-associated colorectal cancer and intestinal homeostasis mediated by the inflammasome and survival pathways. |
| Q34540067 | Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis |
| Q39143046 | Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAP. |
| Q28283505 | Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP |
| Q33632016 | Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins. |
| Q41830995 | Investigating isoquinoline derivatives for inhibition of inhibitor of apoptosis proteins for ovarian cancer treatment |
| Q102144611 | Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo |
| Q35032216 | Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs. |
| Q37980321 | Targeting IAP proteins for therapeutic intervention in cancer |
| Q61809001 | Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment |
| Q51746852 | Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy. |
| Q27679855 | The structure of XIAP BIR2: understanding the selectivity of the BIR domains |
| Q38239689 | X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy. |
Search more.